Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostate Adenocarcinoma: Southwest Oncology Group S0032
Titel:
Phase II Evaluation of Early Oral Estramustine, Oral Etoposide, and Intravenous Paclitaxel Combined With Hormonal Therapy in Patients With High-risk Metastatic Prostate Adenocarcinoma: Southwest Oncology Group S0032
Auteur:
Smith, David C. Tangen, Cathy M. Van Veldhuizen Jr., Peter J. Harrer, Grant W. Golshayan, Ali Mills, Glenn M. Vogelzang, Nicholas J. Thompson, Ian M. Hussain, Maha H.A.